D. Christakidis

477 total citations
15 papers, 384 citations indexed

About

D. Christakidis is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Neurology. According to data from OpenAlex, D. Christakidis has authored 15 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Physiology and 6 papers in Neurology. Recurrent topics in D. Christakidis's work include Diabetic Foot Ulcer Assessment and Management (7 papers), Pain Mechanisms and Treatments (6 papers) and Botulinum Toxin and Related Neurological Disorders (5 papers). D. Christakidis is often cited by papers focused on Diabetic Foot Ulcer Assessment and Management (7 papers), Pain Mechanisms and Treatments (6 papers) and Botulinum Toxin and Related Neurological Disorders (5 papers). D. Christakidis collaborates with scholars based in Greece. D. Christakidis's co-authors include Efstratios Maltezos, Dimitrios Papazoglou, K. Papatheodorou, Νικόλαος Παπάνας, Anna Tavridou, Vangelis G. Manolopoulos, Ioannis Petridis, H. Piperidou, Georgia Ragia and Konstantinos Arvanitidis and has published in prestigious journals such as Clinica Chimica Acta, Drug and Alcohol Dependence and Journal of Diabetes and its Complications.

In The Last Decade

D. Christakidis

15 papers receiving 366 citations

Peers

D. Christakidis
J. D. Ward United Kingdom
Lijin Ji China
Orkide Güzel Türkiye
Kathleen M. Randolph United States
Kimberly D. Bryner United States
D. Christakidis
Citations per year, relative to D. Christakidis D. Christakidis (= 1×) peers Qian Xiong

Countries citing papers authored by D. Christakidis

Since Specialization
Citations

This map shows the geographic impact of D. Christakidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Christakidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Christakidis more than expected).

Fields of papers citing papers by D. Christakidis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Christakidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Christakidis. The network helps show where D. Christakidis may publish in the future.

Co-authorship network of co-authors of D. Christakidis

This figure shows the co-authorship network connecting the top 25 collaborators of D. Christakidis. A scholar is included among the top collaborators of D. Christakidis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Christakidis. D. Christakidis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Trypsianis, Grigorios, et al.. (2010). The sural sensory/radial motor amplitude ratio for the diagnosis of peripheral neuropathy in type 2 diabetic patients.. PubMed. 14(3). 198–202. 4 indexed citations
2.
Tavridou, Anna, et al.. (2010). Association of polymorphisms of the serotonergic system with smoking initiation in Caucasians. Drug and Alcohol Dependence. 108(1-2). 70–76. 20 indexed citations
3.
Tavridou, Anna, Ioannis Petridis, Konstantinos Arvanitidis, et al.. (2009). The serotonin transporter promoter polymorphism (5-HTTLPR) is associated with type 2 diabetes. Clinica Chimica Acta. 411(3-4). 167–171. 48 indexed citations
4.
Ragia, Georgia, Ioannis Petridis, Anna Tavridou, D. Christakidis, & Vangelis G. Manolopoulos. (2009). Presence of CYP2C9*3 Allele Increases Risk for Hypoglycemia in Type 2 Diabetic Patients Treated with Sulfonylureas. Pharmacogenomics. 10(11). 1781–1787. 57 indexed citations
5.
Παπάνας, Νικόλαος, et al.. (2009). METFORMIN AND LACTIC ACIDOSIS IN PATIENTS WITH TYPE 2 DIABETES – FROM PRIDE AND PREJUDICE TO SENSE AND SENSIBILITY. Acta Clinica Belgica. 64(1). 42–48. 4 indexed citations
6.
Tavridou, Anna, Konstantinos Arvanitidis, D. Christakidis, et al.. (2008). The -759C/T polymorphism of the 5-HT2C receptor is associated with type 2 diabetes in male and female Caucasians. Pharmacogenetics and Genomics. 18(2). 153–159. 11 indexed citations
7.
Παπάνας, Νικόλαος, et al.. (2007). An Insertion/Deletion Polymorphism in the Alpha2B Adrenoceptor Gene is Associated with Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus. Experimental and Clinical Endocrinology & Diabetes. 115(5). 327–330. 23 indexed citations
8.
Παπάνας, Νικόλαος, K. Papatheodorou, Dimitrios Papazoglou, et al.. (2007). Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study. Journal of Diabetes and its Complications. 21(6). 353–358. 45 indexed citations
9.
10.
Παπάνας, Νικόλαος, K. Papatheodorou, Dimitrios Papazoglou, et al.. (2007). Use of the New Indicator Test (Neuropad®) for the Assessment of the Staged Severity of Neuropathy in Type 2 Diabetic Patients. Experimental and Clinical Endocrinology & Diabetes. 115(1). 58–61. 18 indexed citations
11.
Παπάνας, Νικόλαος, et al.. (2007). Tool Chest. The Diabetes Educator. 33(2). 257–266. 17 indexed citations
12.
Papazoglou, Dimitrios, et al.. (2006). An Insertion/Deletion Polymorphism in the alpha2B Adrenoceptor Gene is Associated with Age at Onset of Type 2 Diabetes Mellitus. Experimental and Clinical Endocrinology & Diabetes. 114(8). 424–427. 13 indexed citations
13.
Παπάνας, Νικόλαος, K. Papatheodorou, D. Christakidis, et al.. (2005). Evaluation of a New Indicator Test for Sudomotor Function (Neuropad®) in the Diagnosis of Peripheral Neuropathy in Type 2 Diabetic Patients. Experimental and Clinical Endocrinology & Diabetes. 113(4). 195–198. 55 indexed citations
14.
Papatheodorou, K., et al.. (2005). Reproducibility of the New Indicator Test for Sudomotor Function (Neuropad®) in Patients with Type 2 Diabetes Mellitus: Short Communication. Experimental and Clinical Endocrinology & Diabetes. 113(10). 577–581. 28 indexed citations
15.
Maltezos, Efstratios, et al.. (2002). Tumour Necrosis Factor-α Levels in Non-Diabetic Offspring of Patients with Type 2 Diabetes Mellitus. Journal of International Medical Research. 30(6). 576–583. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026